GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (AMEX:CYBN) » Definitions » Change In Payables And Accrued Expense

Cybin (CYBN) Change In Payables And Accrued Expense : $-2.21 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Cybin Change In Payables And Accrued Expense?

Cybin's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $-5.81 Mil. It means Cybin's Accounts Payable & Accrued Expense declined by $5.81 Mil from Sep. 2023 to Dec. 2023 .

Cybin's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2023 was $0.29 Mil. It means Cybin's Accounts Payable & Accrued Expense increased by $0.29 Mil from Mar. 2022 to Mar. 2023 .

Cybin Change In Payables And Accrued Expense Historical Data

The historical data trend for Cybin's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Change In Payables And Accrued Expense Chart

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Change In Payables And Accrued Expense
- 1.43 1.95 0.29

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.38 0.95 0.25 2.40 -5.81

Cybin Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cybin Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cybin's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cybin (CYBN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (AMEX:CYBN) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
TSX:FRX TSX:SVA TSX:ONC NEOE:MMED TSX:EPRX XCNQ:DTC TSXV:NGEN TSX:BCT XCNQ:MSET TSXV:ARCH OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
R7E1:Germany R7E1:Germany CYBN:Canada
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Website
https://www.cybin.com
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.